Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.

Cheung N, Fung TK, Zeisig BB, Holmes K, Rane JK, Mowen KA, Finn MG, Lenhard B, Chan LC, So CW.

Cancer Cell. 2016 Jan 11;29(1):32-48. doi: 10.1016/j.ccell.2015.12.007.

2.

Cis-regulatory mechanisms governing stem and progenitor cell transitions.

Johnson KD, Kong G, Gao X, Chang YI, Hewitt KJ, Sanalkumar R, Prathibha R, Ranheim EA, Dewey CN, Zhang J, Bresnick EH.

Sci Adv. 2015 Sep 4;1(8):e1500503. doi: 10.1126/sciadv.1500503. eCollection 2015 Sep.

3.

Targeting epigenetic regulations in cancer.

Ning B, Li W, Zhao W, Wang R.

Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):97-109. doi: 10.1093/abbs/gmv116. Epub 2015 Oct 26. Review.

PMID:
26508480
4.

Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes.

Alcantara Llaguno SR, Wang Z, Sun D, Chen J, Xu J, Kim E, Hatanpaa KJ, Raisanen JM, Burns DK, Johnson JE, Parada LF.

Cancer Cell. 2015 Oct 12;28(4):429-40. doi: 10.1016/j.ccell.2015.09.007.

PMID:
26461091
5.

Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia.

Ye M, Zhang H, Yang H, Koche R, Staber PB, Cusan M, Levantini E, Welner RS, Bach CS, Zhang J, Krivtsov AV, Armstrong SA, Tenen DG.

Cell Stem Cell. 2015 Nov 5;17(5):611-23. doi: 10.1016/j.stem.2015.08.011. Epub 2015 Sep 24.

PMID:
26412561
6.

Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia.

Lang F, Wojcik B, Rieger MA.

Stem Cells Int. 2015;2015:137164. doi: 10.1155/2015/137164. Epub 2015 Jul 6. Review.

7.

The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis.

Sun XJ, Man N, Tan Y, Nimer SD, Wang L.

Front Oncol. 2015 May 26;5:108. doi: 10.3389/fonc.2015.00108. eCollection 2015. Review.

8.

Zebrafish as a Model for the Study of Human Myeloid Malignancies.

Lu JW, Hsieh MS, Liao HA, Yang YJ, Ho YJ, Lin LI.

Biomed Res Int. 2015;2015:641475. doi: 10.1155/2015/641475. Epub 2015 May 3. Review.

9.

The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.

Giotopoulos G, Chan WI, Horton SJ, Ruau D, Gallipoli P, Fowler A, Crawley C, Papaemmanuil E, Campbell PJ, Göttgens B, Van Deursen JM, Cole PA, Huntly BJ.

Oncogene. 2016 Jan 21;35(3):279-89. doi: 10.1038/onc.2015.92. Epub 2015 Apr 20.

10.

The lysine acetyltransferase activator Brpf1 governs dentate gyrus development through neural stem cells and progenitors.

You L, Yan K, Zou J, Zhao H, Bertos NR, Park M, Wang E, Yang XJ.

PLoS Genet. 2015 Mar 10;11(3):e1005034. doi: 10.1371/journal.pgen.1005034. eCollection 2015 Mar. Erratum in: PLoS Genet. 2015 Jun;11(6):e1005329. Zhou, Jinfeng [corrected to Zou, Jinfeng].

11.

The crossroads between cancer stem cells and aging.

Santos Franco S, Raveh-Amit H, Kobolák J, Alqahtani MH, Mobasheri A, Dinnyes A.

BMC Cancer. 2015;15 Suppl 1:S1. doi: 10.1186/1471-2407-15-S1-S1. Epub 2015 Jan 15. Review.

12.

In vivo molecular imaging of cancer stem cells.

Heryanto YD, Achmad A, Taketomi-Takahashi A, Tsushima Y.

Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):14-26. eCollection 2015. Review.

13.

MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.

Sheikh BN, Lee SC, El-Saafin F, Vanyai HK, Hu Y, Pang SH, Grabow S, Strasser A, Nutt SL, Alexander WS, Smyth GK, Voss AK, Thomas T.

Blood. 2015 Mar 19;125(12):1910-21. doi: 10.1182/blood-2014-08-594655. Epub 2015 Jan 20.

14.

p53 Acetylation: Regulation and Consequences.

Reed SM, Quelle DE.

Cancers (Basel). 2014 Dec 23;7(1):30-69. doi: 10.3390/cancers7010030. Review.

15.

Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.

Aikawa Y, Yamagata K, Katsumoto T, Shima Y, Shino M, Stanley ER, Cleary ML, Akashi K, Tenen DG, Kitabayashi I.

Cancer Sci. 2015 Mar;106(3):227-36. doi: 10.1111/cas.12593. Epub 2015 Feb 12.

16.

Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms.

Rampal R, Ahn J, Abdel-Wahab O, Nahas M, Wang K, Lipson D, Otto GA, Yelensky R, Hricik T, McKenney AS, Chiosis G, Chung YR, Pandey S, van den Brink MR, Armstrong SA, Dogan A, Intlekofer A, Manshouri T, Park CY, Verstovsek S, Rapaport F, Stephens PJ, Miller VA, Levine RL.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5401-10. doi: 10.1073/pnas.1407792111. Epub 2014 Dec 2.

17.

The molecular basis of myeloid malignancies.

Kitamura T, Inoue D, Okochi-Watanabe N, Kato N, Komeno Y, Lu Y, Enomoto Y, Doki N, Uchida T, Kagiyama Y, Togami K, Kawabata KC, Nagase R, Horikawa S, Hayashi Y, Saika M, Fukuyama T, Izawa K, Oki T, Nakahara F, Kitaura J.

Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(10):389-404. Review.

18.

Epigenetics in the hematologic malignancies.

Fong CY, Morison J, Dawson MA.

Haematologica. 2014 Dec;99(12):1772-83. doi: 10.3324/haematol.2013.092007. Review.

19.

BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.

Agarwal A, Mackenzie RJ, Besson A, Jeng S, Carey A, LaTocha DH, Fleischman AG, Duquesnes N, Eide CA, Vasudevan KB, Loriaux MM, Firpo E, Cortes JE, McWeeney S, O'Hare T, Roberts JM, Druker BJ, Deininger MW.

Blood. 2014 Nov 20;124(22):3260-73. doi: 10.1182/blood-2013-04-497040. Epub 2014 Oct 7.

20.

KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.

Turner-Ivey B, Guest ST, Irish JC, Kappler CS, Garrett-Mayer E, Wilson RC, Ethier SP.

Neoplasia. 2014 Aug;16(8):644-55. doi: 10.1016/j.neo.2014.07.007.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk